NISA INVESTMENT ADVISORS, LLC

Position in CCCC — C4 Therapeutics, Inc.

CIK 937615 ST. LOUIS, MO

Position in CCCC

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$728

+$318 QoQ

Shares Held

156

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#144

of 147 holders

Holding Since

Jun 2021

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. CCCC ranks #238 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	56,455	$28,042,892
2	REGN	Regeneron Pharmaceuticals, Inc.	19,412	$12,104,158
3	TECH	BIO-TECHNE Corp	68,452	$4,836,133
4	INCY	Incyte Corp	26,479	$3,001,659
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,139	$2,751,113
6	DFTX	Definium Therapeutics, Inc.	48,369	$2,275,277
7	PRAX	Praxis Precision Medicines, Inc.	6,111	$2,045,901
8	EXEL	Exelixis, Inc.	36,758	$2,000,002

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$728	156	0.0%	Shares	Sole	2026-08-10
2026-03-31	$410	156	0.0%	Shares	Sole	2026-04-30
2025-12-31	$297	156	0.0%	Shares	Sole	2026-01-15
2025-09-30	$346	156	-63.7%	Shares	Sole	2025-10-23
2025-06-30	$614	430	+163.8%	Shares	Sole	2025-07-31
2025-03-31	$260	163	-1.2%	Shares	Sole	2025-04-30
2024-09-30	$940	165	-66.3%	Shares	Sole	2024-10-24
2023-09-30	$911	490	-6.1%	Shares	Sole	2023-11-02
2023-06-30	$1,435	522	-1.1%	Shares	Sole	2023-08-11
2023-03-31	$2	528	-82.9%	Shares	Sole	2023-05-02
2022-12-31	$18,231	3,090	0.0%	Shares	Sole	2023-02-02
2022-09-30	$27,099	3,090	0.0%	Shares	Sole	2022-11-07
2022-06-30	$23,298	3,090	+530.6%	Shares	Sole	2022-08-03
2022-03-31	$11,887	490	-69.8%	Shares	Sole	2022-04-29
2021-12-31	$52,164	1,620	+134.8%	Shares	Sole	2022-02-03
2021-09-30	$30,829	690	0.0%	Shares	Sole	2021-10-18
2021-06-30	$26,109	690	—	Shares	Sole	2021-08-06
No filing history on record for this holder in this stock.